TRIB logo

Trinity Biotech (TRIB) Current Liabilities

Annual Current Liabilities

$15.04 M
-$2.30 M-13.29%

31 December 2023

TRIB Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$28.05 M
+$2.28 M+8.86%

30 September 2024

TRIB Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TRIB Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.3%+120.2%
3 y3 years-44.4%-72.7%
5 y5 years-14.6%+8.3%

TRIB Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-85.0%at low-72.7%+120.2%
5 y5 years-85.0%at low-73.4%+120.2%
alltimeall time-85.0%+784.4%-73.4%+1550.2%

Trinity Biotech Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$28.05 M(+8.9%)
June 2024
-
$25.77 M(+12.9%)
Mar 2024
-
$22.82 M(+51.8%)
Dec 2023
$15.04 M(-13.3%)
$15.04 M(+18.0%)
Sept 2023
-
$12.74 M(-13.7%)
June 2023
-
$14.76 M(-8.6%)
Mar 2023
-
$16.15 M(-6.9%)
Dec 2022
$17.34 M(-82.7%)
$17.34 M(+17.7%)
Sept 2022
-
$14.73 M(+6.1%)
June 2022
-
$13.88 M(-12.9%)
Mar 2022
-
$15.94 M(-84.1%)
Dec 2021
$100.49 M(+271.4%)
$100.49 M(-2.3%)
Sept 2021
-
$102.88 M(-2.6%)
June 2021
-
$105.62 M(+233.8%)
Mar 2021
-
$31.65 M(+17.0%)
Dec 2020
$27.06 M(+39.1%)
$27.06 M(+17.2%)
Sept 2020
-
$23.10 M(+1.5%)
June 2020
-
$22.75 M(+3.1%)
Mar 2020
-
$22.06 M(+13.4%)
Dec 2019
$19.45 M(+10.5%)
$19.45 M(-24.9%)
Sept 2019
-
$25.90 M(+6.1%)
June 2019
-
$24.41 M(+23.2%)
Mar 2019
-
$19.81 M(+12.6%)
Dec 2018
$17.60 M(-17.1%)
$17.60 M(-15.6%)
Sept 2018
-
$20.87 M(+0.3%)
June 2018
-
$20.80 M(-6.1%)
Mar 2018
-
$22.16 M(+4.4%)
Dec 2017
$21.23 M(-16.0%)
$21.23 M(-9.7%)
Sept 2017
-
$23.50 M(+1.2%)
June 2017
-
$23.23 M(+9.8%)
Mar 2017
-
$21.15 M(-16.3%)
Dec 2016
$25.28 M(+25.5%)
$25.28 M(+21.4%)
Sept 2016
-
$20.82 M(+3.5%)
June 2016
-
$20.12 M(-0.9%)
Mar 2016
-
$20.30 M(+0.7%)
Dec 2015
$20.14 M(-8.7%)
$20.14 M(+2.2%)
Sept 2015
-
$19.72 M(-3.0%)
June 2015
-
$20.33 M(-1.6%)
Mar 2015
-
$20.66 M(-6.3%)
Dec 2014
$22.06 M(+5.2%)
$22.06 M(+39.8%)
Sept 2014
-
$15.78 M(-8.3%)
June 2014
-
$17.22 M(+2.8%)
Mar 2014
-
$16.75 M(-20.1%)
Dec 2013
$20.98 M(+61.8%)
$20.98 M(-8.7%)
Sept 2013
-
$22.98 M(+57.1%)
June 2013
-
$14.63 M(+2.5%)
Mar 2013
-
$14.27 M(+10.0%)
Dec 2012
$12.97 M(-2.7%)
$12.97 M(-6.8%)
Sept 2012
-
$13.91 M(+2.6%)
June 2012
-
$13.55 M(+12.0%)
Mar 2012
-
$12.10 M(-9.2%)
Dec 2011
$13.33 M(+8.8%)
$13.33 M(+7.3%)
Sept 2011
-
$12.43 M(-5.5%)
June 2011
-
$13.15 M(-4.7%)
Mar 2011
-
$13.79 M(+12.5%)
DateAnnualQuarterly
Dec 2010
$12.26 M(-52.1%)
$12.26 M(-9.9%)
Sept 2010
-
$13.60 M(+3.9%)
June 2010
-
$13.09 M(-49.1%)
Mar 2010
-
$25.70 M(+0.4%)
Dec 2009
$25.60 M(-28.3%)
$25.60 M(-17.9%)
Sept 2009
-
$31.18 M(-6.4%)
June 2009
-
$33.31 M(+2.1%)
Mar 2009
-
$32.63 M(-8.6%)
Dec 2008
$35.71 M(-17.9%)
$35.71 M(+3.3%)
Sept 2008
-
$34.55 M(+5.6%)
June 2008
-
$32.73 M(-23.2%)
Mar 2008
-
$42.59 M(-2.1%)
Dec 2007
$43.51 M(+21.1%)
$43.51 M(+29.9%)
June 2007
-
$33.49 M(-3.8%)
Mar 2007
-
$34.84 M(-3.1%)
Dec 2006
$35.94 M(+12.7%)
$35.94 M(-6.4%)
Sept 2006
-
$38.40 M(+11.4%)
June 2006
-
$34.46 M(+26.8%)
Mar 2006
-
$27.17 M(-14.8%)
Dec 2005
$31.90 M(+57.5%)
$31.90 M(+12.9%)
Sept 2005
-
$28.25 M(+32.9%)
June 2005
-
$21.26 M(+4.3%)
Mar 2005
-
$20.39 M(+0.6%)
Dec 2004
$20.26 M(+4.4%)
$20.26 M(+34.1%)
Sept 2004
-
$15.11 M(+5.4%)
June 2004
-
$14.33 M(-19.2%)
Mar 2004
-
$17.74 M(-8.6%)
Dec 2003
$19.40 M(+2.6%)
$19.40 M(+33.5%)
Sept 2003
-
$14.54 M(-11.1%)
June 2003
-
$16.35 M(-15.0%)
Mar 2003
-
$19.24 M(+1.7%)
Dec 2002
$18.91 M(+49.0%)
$18.91 M(+37.7%)
Sept 2002
-
$13.73 M(+16.1%)
June 2002
-
$11.84 M(-8.7%)
Mar 2002
-
$12.96 M(+2.1%)
Dec 2001
$12.69 M(+27.9%)
$12.69 M(+61.9%)
Sept 2001
-
$7.84 M(-14.6%)
June 2001
-
$9.18 M(-1.7%)
Mar 2001
-
$9.35 M(-5.8%)
Dec 2000
$9.92 M(-30.3%)
$9.92 M(+88.2%)
Sept 2000
-
$5.27 M(-32.5%)
June 2000
-
$7.81 M(-41.2%)
Mar 2000
-
$13.28 M(-6.7%)
Dec 1999
$14.23 M(-21.4%)
$14.23 M(-23.1%)
Sept 1999
-
$18.50 M(-5.6%)
June 1999
-
$19.60 M(+21.0%)
Mar 1999
-
$16.20 M(-10.5%)
Dec 1998
$18.10 M(+105.7%)
$18.10 M(+57.4%)
Sept 1998
-
$11.50 M(+30.7%)
June 1998
-
$8.80 M(0.0%)
Dec 1997
$8.80 M(+193.3%)
$8.80 M(+193.3%)
Dec 1996
$3.00 M(+76.5%)
$3.00 M(+76.5%)
Dec 1995
$1.70 M(-5.6%)
$1.70 M(0.0%)
Dec 1994
$1.80 M(+5.9%)
-
Feb 1994
-
$1.70 M
Feb 1994
$1.70 M
-

FAQ

  • What is Trinity Biotech annual total current liabilities?
  • What is the all time high annual current liabilities for Trinity Biotech?
  • What is Trinity Biotech annual current liabilities year-on-year change?
  • What is Trinity Biotech quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Trinity Biotech?
  • What is Trinity Biotech quarterly current liabilities year-on-year change?

What is Trinity Biotech annual total current liabilities?

The current annual current liabilities of TRIB is $15.04 M

What is the all time high annual current liabilities for Trinity Biotech?

Trinity Biotech all-time high annual total current liabilities is $100.49 M

What is Trinity Biotech annual current liabilities year-on-year change?

Over the past year, TRIB annual total current liabilities has changed by -$2.30 M (-13.29%)

What is Trinity Biotech quarterly total current liabilities?

The current quarterly current liabilities of TRIB is $28.05 M

What is the all time high quarterly current liabilities for Trinity Biotech?

Trinity Biotech all-time high quarterly total current liabilities is $105.62 M

What is Trinity Biotech quarterly current liabilities year-on-year change?

Over the past year, TRIB quarterly total current liabilities has changed by +$15.32 M (+120.24%)